Does the cytokine adsorber CytoSorb ® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study.
Christina ScharfFerdinand WeineltInes SchroederMichael PaalMichael WeigandMichael ZollerMichael IrlbeckCharlotte KloftJosef BriegelUwe LiebchenPublished in: Annals of intensive care (2022)
treatment to avoid subtherapeutic concentrations. Trial registration NCT03985605. Registered 14 June 2019, https://clinicaltrials.gov/ct2/show/NCT03985605.